The Patent Finder

Terms ending in 2041

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,144,825Cellular Immunotherapy for Repetitive Administration
In force
 · High confidence
CellectisIn forceHigh confidence
US 12,319,784Polymeric Material and Use Thereof
In force
 · High confidence
CellectisIn forceHigh confidence
US 12,365,733Method for Improving Production of Car T Cells
In force
 · High confidence
CellectisIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited